Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview
- 29 April 2017
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 35 (7) , 673-683
Abstract
Decision-analytic models for cost-effectiveness analysis are developed in a variety of software packages where the accuracy of the computer code is seldom verified. Although modeling guidelines recommend using state-of-the-art quality assurance and control methods for software engineering to verify models, the fields of pharmacoeconomics and health technology assessment (HTA) have yet to establish and adopt guidance on how to verify health and economic models. The objective of this paper is to introduce to our field the variety of methods the software engineering field uses to verify that software performs as expected. We identify how many of these methods can be incorporated in the development process of decision-analytic models in order to reduce errors and increase transparency. Given the breadth of methods used in software engineering, we recommend a more in-depth initiative to be undertaken (e.g., by an ISPOR-SMDM Task Force) to define the best practices for model verification in our field and to accelerate adoption. Establishing a general guidance for verifying models will benefit the pharmacoeconomics and HTA communities by increasing accuracy of computer programming, transparency, accessibility, sharing, understandability, and trust of models.Keywords
This publication has 32 references indexed in Scilit:
- AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model UsersPharmacoEconomics, 2015
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United StatesAnnals of Internal Medicine, 2015
- Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic ModelsPharmacoEconomics, 2014
- Conceptualizing a ModelMedical Decision Making, 2012
- Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7Value in Health, 2012
- Avoiding and identifying errors in health technology assessment models: qualitative study and methodological reviewHealth Technology Assessment, 2010
- Comparing Three Software Tools for Implementing Markov Models for Health Economic EvaluationsPharmacoEconomics, 2009
- Numerical Methods for Ordinary Differential Equations2003
- Representing uncertainty: the role of cost‐effectiveness acceptability curvesHealth Economics, 2001
- The Markov Process in Medical PrognosisMedical Decision Making, 1983